hydration benefits glp-1 receptor agonists Glucagon-like peptide-1 (GLP-1) (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are medications that reduce food cravings, increase fullness, slow digestion, and can help control Long-term Success of GLP-1s Hinges

After the 56-week treatment period, BMI standard deviation scores (BMI SDS) decreased by a mean of 0.23 in the liraglutide group, with no change in the placebo group

Among the Eli Lilly trials is one for orforglipron (LY3502970), a novel, oral non-peptide GLP-1 RA, which is the subject of four trials in the clinicaltrials.gov data

Diabete Metab 2008

Loss of lean muscle mass has been noted in up to 25% of patients undergoing rapid weight loss

Human gut microbiome: hopes, threats and promises

Rising Demand for Convenient Obesity and Diabetes Therapies The rising number of cases of obesity and type 2 diabetes will contribute significantly to the market's expansion within the forecast period